Genes and Proteins Governing the Cellular Sensitivity to HSP90 Inhibitors: A Mechanistic Perspective

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|3|5|331-341

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.5, 2003-10, pp. : 331-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Macrocyclic Inhibitors of Hsp90

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 14, 2010-10 ,pp. : 1380-1402

Bentham Science Publishers

Access to resources Recommend Favorite

Medicinal Chemistry of Hsp90 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-07 ,pp. : 859-868

Bentham Science Publishers

Access to resources Recommend Favorite

Purine-Scaffold Hsp90 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 15, 2009-11 ,pp. : 1436-1446

Bentham Science Publishers

Access to resources Recommend Favorite

IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma

By  

Current Medicinal Chemistry, Vol. 21, Iss. 26, 2014-09 ,pp. : 3042-3047

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and development of purine-scaffold Hsp90 inhibitors

By Chiosis Gabriela   Kang Yanlong   Sun Weilin  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 1, 2008-01 ,pp. : 99-114

Informa Healthcare

Access to resources Recommend Favorite